View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsGABY 過去の業績過去 基準チェック /06GABYの収益は年間平均-26.4%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間37.1% 51%割合で 増加しています。主要情報-26.43%収益成長率27.86%EPS成長率Pharmaceuticals 業界の成長23.06%収益成長率50.98%株主資本利益率n/aネット・マージン-154.72%前回の決算情報31 Mar 2023最近の業績更新Reported Earnings • Jun 02First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: US$4.74m (down 18% from 1Q 2022). Net loss: US$1.56m (down 224% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings.Reported Earnings • May 03Full year 2022 earnings released: US$0.04 loss per share (vs US$0.018 loss in FY 2021)Full year 2022 results: US$0.04 loss per share (further deteriorated from US$0.018 loss in FY 2021). Revenue: US$21.8m (down 15% from FY 2021). Net loss: US$29.3m (loss widened 202% from FY 2021). Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings.Reported Earnings • Dec 01Third quarter 2022 earnings released: US$0.005 loss per share (vs US$0.005 loss in 3Q 2021)Third quarter 2022 results: US$0.005 loss per share (in line with 3Q 2021). Revenue: US$5.35m (down 29% from 3Q 2021). Net loss: US$3.76m (loss widened 10% from 3Q 2021).Reported Earnings • Aug 30Second quarter 2022 earnings released: US$0.004 loss per share (vs US$0.002 loss in 2Q 2021)Second quarter 2022 results: US$0.004 loss per share (down from US$0.002 loss in 2Q 2021). Revenue: US$5.18m (down 44% from 2Q 2021). Net loss: US$3.04m (loss widened 136% from 2Q 2021).Reported Earnings • May 31First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: CA$7.33m (up 115% from 1Q 2021). Net income: CA$1.55m (up CA$4.07m from 1Q 2021). Profit margin: 21% (up from net loss in 1Q 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has fallen by 62% per year, which means it is significantly lagging earnings.Reported Earnings • May 01Full year 2021 earnings released: CA$0.023 loss per share (vs CA$0.056 loss in FY 2020)Full year 2021 results: CA$0.023 loss per share (up from CA$0.056 loss in FY 2020). Revenue: CA$32.4m (up CA$28.4m from FY 2020). Net loss: CA$12.2m (loss narrowed 4.5% from FY 2020). Over the next year, revenue is forecast to grow 26%, compared to a 14% growth forecast for the industry in Canada. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 59% per year, which means it is significantly lagging earnings.すべての更新を表示Recent updatesお知らせ • Aug 18+ 1 more updateGABY Inc. Announces Executive ResignationsGABY Inc. announced that it is immediately winding down operations which is expected to be concluded by August 31, 2023. The Board of Directors and the sole remaining officers of the Company, Simon Lileikis, Interim CEO and President and Leanne Likness, Corporate Secretary have resigned their respective offices effective immediately.Reported Earnings • Jun 02First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: US$4.74m (down 18% from 1Q 2022). Net loss: US$1.56m (down 224% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings.お知らせ • May 04Ggaby Inc. Announces CEO ChangesGABY Inc. announced that Margot Micallef, the Company's Founder and Chief Executive Officer ("CEO"), will take a temporary leave of absence from her role as CEO of the Company. Ms. Micallef is temporarily resigning her position as CEO for personal reasons but will continue to represent the Company as its Chair and serve on the board of directors of GABY (the "Board"). The Board has appointed Simon Lileikis, GABY's current President, to serve as the Company's Interim CEO. Mr. Lileikis was appointed President of GABY in 2021.Reported Earnings • May 03Full year 2022 earnings released: US$0.04 loss per share (vs US$0.018 loss in FY 2021)Full year 2022 results: US$0.04 loss per share (further deteriorated from US$0.018 loss in FY 2021). Revenue: US$21.8m (down 15% from FY 2021). Net loss: US$29.3m (loss widened 202% from FY 2021). Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings.分析記事 • Feb 11Health Check: How Prudently Does GABY (CSE:GABY) Use Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Dec 01Third quarter 2022 earnings released: US$0.005 loss per share (vs US$0.005 loss in 3Q 2021)Third quarter 2022 results: US$0.005 loss per share (in line with 3Q 2021). Revenue: US$5.35m (down 29% from 3Q 2021). Net loss: US$3.76m (loss widened 10% from 3Q 2021).Reported Earnings • Aug 30Second quarter 2022 earnings released: US$0.004 loss per share (vs US$0.002 loss in 2Q 2021)Second quarter 2022 results: US$0.004 loss per share (down from US$0.002 loss in 2Q 2021). Revenue: US$5.18m (down 44% from 2Q 2021). Net loss: US$3.04m (loss widened 136% from 2Q 2021).お知らせ • Jul 19Gaby Inc. Announces Changes to its Board of DirectorsGABY Inc. announce that Glenn Solomon QC has been appointed to the Board of Directors, effective July 14, 2022. Mr. Solomon replaces Mr. Loreto Grimaldi who stepped down from the Board effective, July 13, 2022. Mr. Solomon is a Calgary lawyer and businessperson. He has a BA (University of Calgary), a law degree (University of Alberta) and two Masters of Law Degrees (Osgoode Hall Law School, York University, Toronto), as well as a "Director" designation from the Institute of Corporate Directors (ICD.D). Mr. Solomon is a Fellow of the Chartered Institute of Arbitrators (UK) and a Fellow of Litigation Counsel of America which is limited to one-half of one percent of lawyers. In 2010, Mr. Solomon was awarded a Queen's Counsel designation by the Lieutenant Governor on behalf of the Queen in Right of Alberta, an honor bestowed on only the highest-ranking lawyers. He has also been honoured as a recipient of the Alberta Centennial Medal in recognition of his significant contributions to his fellow citizens, his community and Alberta, and was honoured as a recipient of the Queen Elizabeth II Diamond Jubilee Medal in 2012 in recognition of his significant contribution to his countrymen and his community. Mr. Solomon has had an AV Preeminent peer review rating continuously since 2012, and an AV Preeminent judicial review rating continuously since 2015, in legal ability and ethical standards from LexisNexis Martindale-Hubbell and Lawyers.com - the higher rating given. He has also been consistently recognized as a peer-reviewed leading practitioner by Best Lawyers in Canada in Corporate and Commercial Litigation since 2015, and in Privacy and Data Security since 2021. In 2022, Best Lawyers in Canada recognized Mr. Solomon as the "Lawyer of the Year" in Privacy and Data Security in Calgary. He has been recognized as a "Litigation Star" by Benchmark Litigation since 2012, in the areas of Administrative Law, Arbitration, Commercial Litigation, Energy Litigation and Insurance Litigation. Since 2014, Mr. Solomon has been recognized as a distinguished practitioner in Dispute Resolution by Chambers Global, the internationally renowned legal directory. Mr. Solomon has been recognized among Litigation and Product Liability Lawyers by Legal Media Group Guides to the Litigation Lawyers, Expert Guides (2014 - 2016), as a "Top Rated Lawyer in Canada" by Corporate Counsel Magazine (2013 - 2014), The American Lawyer Magazine (2013 - 2014), and American Lawyer Media (2013 - 2014).Reported Earnings • May 31First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: CA$7.33m (up 115% from 1Q 2021). Net income: CA$1.55m (up CA$4.07m from 1Q 2021). Profit margin: 21% (up from net loss in 1Q 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has fallen by 62% per year, which means it is significantly lagging earnings.Reported Earnings • May 01Full year 2021 earnings released: CA$0.023 loss per share (vs CA$0.056 loss in FY 2020)Full year 2021 results: CA$0.023 loss per share (up from CA$0.056 loss in FY 2020). Revenue: CA$32.4m (up CA$28.4m from FY 2020). Net loss: CA$12.2m (loss narrowed 4.5% from FY 2020). Over the next year, revenue is forecast to grow 26%, compared to a 14% growth forecast for the industry in Canada. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 59% per year, which means it is significantly lagging earnings.お知らせ • Mar 04+ 1 more updateGaby Inc. Appoints Paul Stacey to the Role of Senior Vice-President FinanceGABY Inc. announced the appointment of Paul Stacey to the role of Senior Vice-President Finance effective immediately. Mr. Stacey is a seasoned CFO and brings with him extensive and relevant industry experience, and strong executive leadership in the areas of corporate finance, financial planning, strategy and operations. Mr. Stacey served as the Chief Financial Officer of Dr. Murphys - a well-respected cannabis extraction and distribution facility with its own brand in market. Prior to Dr. Murphys, Paul was variably the CFO or the COO of a number of businesses or start-ups through a partnership with private equity funds. As a partner or advisor to private equity firms Paul managed and improved cashflow, grew revenues and optimized assets and pricing for a number of private equity owned consumer packaged goods companies. Earlier in his career, Paul held leadership roles with Gund, Ricoh USA, Cendant and Nabisco. He started his career as an auditor with PricewaterhouseCoopers.Board Change • Dec 31High number of new directorsIndependent Director Loreto Grimaldi was the last director to join the board, commencing their role in 2021.Reported Earnings • Nov 26Third quarter 2021 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2021 results: CA$0.006 loss per share (vs CA$0.006 loss in 3Q 2020). Revenue: CA$9.53m (up CA$8.72m from 3Q 2020). Net loss: CA$4.29m (loss widened 209% from 3Q 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 57% per year, which means it is significantly lagging earnings.Reported Earnings • Sep 01Second quarter 2021 earnings released: CA$0.003 loss per share (vs CA$0.007 loss in 2Q 2020)The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: CA$11.3m (up CA$10.5m from 2Q 2020). Net loss: CA$1.58m (loss narrowed 6.6% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 57% per year, which means it is significantly lagging earnings.お知らせ • Jun 18GABY Inc. Announces State-Wide Launch of New Lifestyle Cannabis Brand, Kind RepublicGABY Inc. announced the statewide launch of Kind Republic™, a California based lifestyle cannabis brand. Formerly an exclusive brand to Mankind Dispensary, it is set to launch state-wide on June 28, 2021. Manufactured and distributed by GABY owned Sonoma Pacific Distribution Inc. ("Sonoma Pacific"), Kind RepublicTM products will soon be available in dispensaries across the State of California. Kind RepublicTM caters to Californian's outdoor lifestyle culture, launching with a selection of prerolls, concentrates, and flower, cultivated and crafted in California keeping with the dispensary's high-quality roster of cannabis products. The new offerings will be promoted across the state and will also remain available to purchase in-store and online, through Mankind Dispensary.Reported Earnings • May 13Full year 2020 earnings releasedThe company reported a soft full year result with weaker revenues and control over costs, although losses reduced. Full year 2020 results: Revenue: CA$4.07m (down 63% from FY 2019). Net loss: CA$12.8m (loss narrowed 44% from FY 2019).お知らせ • Feb 05GABY Inc. announced that it has received CAD 8.646456 million in fundingOn February 4, 2021, GABY Inc. (CNSX:GABY) closed the transaction. The company issued 172,929,123 subscription receipts for gross proceeds of CAD 8,646,456.15.お知らせ • Jan 23GABY Inc., Annual General Meeting, Mar 25, 2021GABY Inc., Annual General Meeting, Mar 25, 2021.お知らせ • Jan 09GABY Inc. to Appoint Javier Estades to its Board of DirectorsGABY Inc. will appoint Javier Estades to its board of directors. As President and CEO of Tabacalera USA Inc., Javier's expertise in branding, customer experience, retail strategy, and online sales, will be invaluable to the future of GABY.お知らせ • Dec 04+ 1 more updateGABY Inc. announced that it expects to receive CAD 11 million in fundingGABY Inc. (CNSX:GABY) announced that it has entered into an agreement for a brokered best efforts private placement of 220,000,000 subscription receipts at a price of CAD 0.05 per subscription receipt for gross proceeds of CAD 11,000,000 on December 3, 2020. Each subscription receipt will entitle the holder to purchase units of the company. Each unit will consist of one common share and one share purchase warrant. Each warrant will entitle the holder to purchase a common share at a price of CAD 0.09 per share for a period of 24 months from issuance, provided that if, at any time prior to the expiry date of the Warrants, the volume weighted average trading price of the common shares on the CSE, or other principal exchange on which the company's shares are listed, is greater than C$0.18 for 5 consecutive trading days. The company has granted the agents option to offer up to additional 15% of the number of subscription receipts sold at any time up to 48 hours prior to the closing. The transaction is expected to close on or about the week of December 21, 2020.分析記事 • Dec 02Are Insiders Buying GABY Inc. (CSE:GABY) Stock?It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...収支内訳GABY の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史CNSX:GABY 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費31 Mar 2321-3210031 Dec 2222-2910030 Sep 2221-810030 Jun 2224-811031 Mar 2229-611031 Dec 2126-1010030 Sep 2120-128030 Jun 2113-107031 Mar 215-105031 Dec 203-106030 Sep 204-147030 Jun 207-148031 Mar 208-159031 Dec 198-159030 Sep 196-88030 Jun 192-87031 Mar 191-65031 Dec 181-64030 Sep 181-53030 Jun 181-43031 Mar 181-32031 Dec 171-32031 Dec 160-22031 Dec 150-220質の高い収益: GABYは現在利益が出ていません。利益率の向上: GABYは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: GABYは利益が出ておらず、過去 5 年間で損失は年間26.4%の割合で増加しています。成長の加速: GABYの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: GABYは利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( 256.2% ) と比較することは困難です。株主資本利益率高いROE: GABYの負債は資産を上回っているため、自己資本利益率を計算することは困難です。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/12/04 14:23終値2023/09/06 00:00収益2023/03/31年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋GABY Inc. これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Joseph GomesNOBLE Capital Markets, Inc.
Reported Earnings • Jun 02First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: US$4.74m (down 18% from 1Q 2022). Net loss: US$1.56m (down 224% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings.
Reported Earnings • May 03Full year 2022 earnings released: US$0.04 loss per share (vs US$0.018 loss in FY 2021)Full year 2022 results: US$0.04 loss per share (further deteriorated from US$0.018 loss in FY 2021). Revenue: US$21.8m (down 15% from FY 2021). Net loss: US$29.3m (loss widened 202% from FY 2021). Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings.
Reported Earnings • Dec 01Third quarter 2022 earnings released: US$0.005 loss per share (vs US$0.005 loss in 3Q 2021)Third quarter 2022 results: US$0.005 loss per share (in line with 3Q 2021). Revenue: US$5.35m (down 29% from 3Q 2021). Net loss: US$3.76m (loss widened 10% from 3Q 2021).
Reported Earnings • Aug 30Second quarter 2022 earnings released: US$0.004 loss per share (vs US$0.002 loss in 2Q 2021)Second quarter 2022 results: US$0.004 loss per share (down from US$0.002 loss in 2Q 2021). Revenue: US$5.18m (down 44% from 2Q 2021). Net loss: US$3.04m (loss widened 136% from 2Q 2021).
Reported Earnings • May 31First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: CA$7.33m (up 115% from 1Q 2021). Net income: CA$1.55m (up CA$4.07m from 1Q 2021). Profit margin: 21% (up from net loss in 1Q 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has fallen by 62% per year, which means it is significantly lagging earnings.
Reported Earnings • May 01Full year 2021 earnings released: CA$0.023 loss per share (vs CA$0.056 loss in FY 2020)Full year 2021 results: CA$0.023 loss per share (up from CA$0.056 loss in FY 2020). Revenue: CA$32.4m (up CA$28.4m from FY 2020). Net loss: CA$12.2m (loss narrowed 4.5% from FY 2020). Over the next year, revenue is forecast to grow 26%, compared to a 14% growth forecast for the industry in Canada. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 59% per year, which means it is significantly lagging earnings.
お知らせ • Aug 18+ 1 more updateGABY Inc. Announces Executive ResignationsGABY Inc. announced that it is immediately winding down operations which is expected to be concluded by August 31, 2023. The Board of Directors and the sole remaining officers of the Company, Simon Lileikis, Interim CEO and President and Leanne Likness, Corporate Secretary have resigned their respective offices effective immediately.
Reported Earnings • Jun 02First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: US$4.74m (down 18% from 1Q 2022). Net loss: US$1.56m (down 224% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings.
お知らせ • May 04Ggaby Inc. Announces CEO ChangesGABY Inc. announced that Margot Micallef, the Company's Founder and Chief Executive Officer ("CEO"), will take a temporary leave of absence from her role as CEO of the Company. Ms. Micallef is temporarily resigning her position as CEO for personal reasons but will continue to represent the Company as its Chair and serve on the board of directors of GABY (the "Board"). The Board has appointed Simon Lileikis, GABY's current President, to serve as the Company's Interim CEO. Mr. Lileikis was appointed President of GABY in 2021.
Reported Earnings • May 03Full year 2022 earnings released: US$0.04 loss per share (vs US$0.018 loss in FY 2021)Full year 2022 results: US$0.04 loss per share (further deteriorated from US$0.018 loss in FY 2021). Revenue: US$21.8m (down 15% from FY 2021). Net loss: US$29.3m (loss widened 202% from FY 2021). Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings.
分析記事 • Feb 11Health Check: How Prudently Does GABY (CSE:GABY) Use Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Dec 01Third quarter 2022 earnings released: US$0.005 loss per share (vs US$0.005 loss in 3Q 2021)Third quarter 2022 results: US$0.005 loss per share (in line with 3Q 2021). Revenue: US$5.35m (down 29% from 3Q 2021). Net loss: US$3.76m (loss widened 10% from 3Q 2021).
Reported Earnings • Aug 30Second quarter 2022 earnings released: US$0.004 loss per share (vs US$0.002 loss in 2Q 2021)Second quarter 2022 results: US$0.004 loss per share (down from US$0.002 loss in 2Q 2021). Revenue: US$5.18m (down 44% from 2Q 2021). Net loss: US$3.04m (loss widened 136% from 2Q 2021).
お知らせ • Jul 19Gaby Inc. Announces Changes to its Board of DirectorsGABY Inc. announce that Glenn Solomon QC has been appointed to the Board of Directors, effective July 14, 2022. Mr. Solomon replaces Mr. Loreto Grimaldi who stepped down from the Board effective, July 13, 2022. Mr. Solomon is a Calgary lawyer and businessperson. He has a BA (University of Calgary), a law degree (University of Alberta) and two Masters of Law Degrees (Osgoode Hall Law School, York University, Toronto), as well as a "Director" designation from the Institute of Corporate Directors (ICD.D). Mr. Solomon is a Fellow of the Chartered Institute of Arbitrators (UK) and a Fellow of Litigation Counsel of America which is limited to one-half of one percent of lawyers. In 2010, Mr. Solomon was awarded a Queen's Counsel designation by the Lieutenant Governor on behalf of the Queen in Right of Alberta, an honor bestowed on only the highest-ranking lawyers. He has also been honoured as a recipient of the Alberta Centennial Medal in recognition of his significant contributions to his fellow citizens, his community and Alberta, and was honoured as a recipient of the Queen Elizabeth II Diamond Jubilee Medal in 2012 in recognition of his significant contribution to his countrymen and his community. Mr. Solomon has had an AV Preeminent peer review rating continuously since 2012, and an AV Preeminent judicial review rating continuously since 2015, in legal ability and ethical standards from LexisNexis Martindale-Hubbell and Lawyers.com - the higher rating given. He has also been consistently recognized as a peer-reviewed leading practitioner by Best Lawyers in Canada in Corporate and Commercial Litigation since 2015, and in Privacy and Data Security since 2021. In 2022, Best Lawyers in Canada recognized Mr. Solomon as the "Lawyer of the Year" in Privacy and Data Security in Calgary. He has been recognized as a "Litigation Star" by Benchmark Litigation since 2012, in the areas of Administrative Law, Arbitration, Commercial Litigation, Energy Litigation and Insurance Litigation. Since 2014, Mr. Solomon has been recognized as a distinguished practitioner in Dispute Resolution by Chambers Global, the internationally renowned legal directory. Mr. Solomon has been recognized among Litigation and Product Liability Lawyers by Legal Media Group Guides to the Litigation Lawyers, Expert Guides (2014 - 2016), as a "Top Rated Lawyer in Canada" by Corporate Counsel Magazine (2013 - 2014), The American Lawyer Magazine (2013 - 2014), and American Lawyer Media (2013 - 2014).
Reported Earnings • May 31First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: CA$7.33m (up 115% from 1Q 2021). Net income: CA$1.55m (up CA$4.07m from 1Q 2021). Profit margin: 21% (up from net loss in 1Q 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has fallen by 62% per year, which means it is significantly lagging earnings.
Reported Earnings • May 01Full year 2021 earnings released: CA$0.023 loss per share (vs CA$0.056 loss in FY 2020)Full year 2021 results: CA$0.023 loss per share (up from CA$0.056 loss in FY 2020). Revenue: CA$32.4m (up CA$28.4m from FY 2020). Net loss: CA$12.2m (loss narrowed 4.5% from FY 2020). Over the next year, revenue is forecast to grow 26%, compared to a 14% growth forecast for the industry in Canada. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 59% per year, which means it is significantly lagging earnings.
お知らせ • Mar 04+ 1 more updateGaby Inc. Appoints Paul Stacey to the Role of Senior Vice-President FinanceGABY Inc. announced the appointment of Paul Stacey to the role of Senior Vice-President Finance effective immediately. Mr. Stacey is a seasoned CFO and brings with him extensive and relevant industry experience, and strong executive leadership in the areas of corporate finance, financial planning, strategy and operations. Mr. Stacey served as the Chief Financial Officer of Dr. Murphys - a well-respected cannabis extraction and distribution facility with its own brand in market. Prior to Dr. Murphys, Paul was variably the CFO or the COO of a number of businesses or start-ups through a partnership with private equity funds. As a partner or advisor to private equity firms Paul managed and improved cashflow, grew revenues and optimized assets and pricing for a number of private equity owned consumer packaged goods companies. Earlier in his career, Paul held leadership roles with Gund, Ricoh USA, Cendant and Nabisco. He started his career as an auditor with PricewaterhouseCoopers.
Board Change • Dec 31High number of new directorsIndependent Director Loreto Grimaldi was the last director to join the board, commencing their role in 2021.
Reported Earnings • Nov 26Third quarter 2021 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2021 results: CA$0.006 loss per share (vs CA$0.006 loss in 3Q 2020). Revenue: CA$9.53m (up CA$8.72m from 3Q 2020). Net loss: CA$4.29m (loss widened 209% from 3Q 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 57% per year, which means it is significantly lagging earnings.
Reported Earnings • Sep 01Second quarter 2021 earnings released: CA$0.003 loss per share (vs CA$0.007 loss in 2Q 2020)The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: CA$11.3m (up CA$10.5m from 2Q 2020). Net loss: CA$1.58m (loss narrowed 6.6% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 57% per year, which means it is significantly lagging earnings.
お知らせ • Jun 18GABY Inc. Announces State-Wide Launch of New Lifestyle Cannabis Brand, Kind RepublicGABY Inc. announced the statewide launch of Kind Republic™, a California based lifestyle cannabis brand. Formerly an exclusive brand to Mankind Dispensary, it is set to launch state-wide on June 28, 2021. Manufactured and distributed by GABY owned Sonoma Pacific Distribution Inc. ("Sonoma Pacific"), Kind RepublicTM products will soon be available in dispensaries across the State of California. Kind RepublicTM caters to Californian's outdoor lifestyle culture, launching with a selection of prerolls, concentrates, and flower, cultivated and crafted in California keeping with the dispensary's high-quality roster of cannabis products. The new offerings will be promoted across the state and will also remain available to purchase in-store and online, through Mankind Dispensary.
Reported Earnings • May 13Full year 2020 earnings releasedThe company reported a soft full year result with weaker revenues and control over costs, although losses reduced. Full year 2020 results: Revenue: CA$4.07m (down 63% from FY 2019). Net loss: CA$12.8m (loss narrowed 44% from FY 2019).
お知らせ • Feb 05GABY Inc. announced that it has received CAD 8.646456 million in fundingOn February 4, 2021, GABY Inc. (CNSX:GABY) closed the transaction. The company issued 172,929,123 subscription receipts for gross proceeds of CAD 8,646,456.15.
お知らせ • Jan 23GABY Inc., Annual General Meeting, Mar 25, 2021GABY Inc., Annual General Meeting, Mar 25, 2021.
お知らせ • Jan 09GABY Inc. to Appoint Javier Estades to its Board of DirectorsGABY Inc. will appoint Javier Estades to its board of directors. As President and CEO of Tabacalera USA Inc., Javier's expertise in branding, customer experience, retail strategy, and online sales, will be invaluable to the future of GABY.
お知らせ • Dec 04+ 1 more updateGABY Inc. announced that it expects to receive CAD 11 million in fundingGABY Inc. (CNSX:GABY) announced that it has entered into an agreement for a brokered best efforts private placement of 220,000,000 subscription receipts at a price of CAD 0.05 per subscription receipt for gross proceeds of CAD 11,000,000 on December 3, 2020. Each subscription receipt will entitle the holder to purchase units of the company. Each unit will consist of one common share and one share purchase warrant. Each warrant will entitle the holder to purchase a common share at a price of CAD 0.09 per share for a period of 24 months from issuance, provided that if, at any time prior to the expiry date of the Warrants, the volume weighted average trading price of the common shares on the CSE, or other principal exchange on which the company's shares are listed, is greater than C$0.18 for 5 consecutive trading days. The company has granted the agents option to offer up to additional 15% of the number of subscription receipts sold at any time up to 48 hours prior to the closing. The transaction is expected to close on or about the week of December 21, 2020.
分析記事 • Dec 02Are Insiders Buying GABY Inc. (CSE:GABY) Stock?It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...